Skip to content
10-Q

Quarterly Report

ORCHARD THERAPEUTICS PLC

0000950170-23-041422

← back to feed
Filed
Aug 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 31, 2023 227.23M sh
Shares Diluted Q2 2023 · Jun 30, 2023 189.29M sh
Shares Diluted Q2 2023 · Jun 30, 2023 165.48M sh
Shares Diluted Q2 2023 · Jun 30, 2022 127.85M sh
Shares Diluted Q2 2023 · Jun 30, 2022 127.78M sh
Capex Q2 2023 · Jun 30, 2023 $483K
Capex Q2 2023 · Jun 30, 2022 $1.57M
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$57.34M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$45.98M
Long Term Debt Q2 2023 · Jun 30, 2023 $18.44M
Long Term Debt Q2 2023 · Dec 31, 2022 $22.99M
Short Term Debt Q2 2023 · Jun 30, 2023 $9.43M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $38.27M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $68.42M
Stockholders Equity Q2 2023 · Jun 30, 2023 $109.05M
Stockholders Equity Q2 2023 · Mar 31, 2023 $101.66M
Stockholders Equity Q2 2023 · Dec 31, 2022 $98.26M
Stockholders Equity Q2 2023 · Jun 30, 2022 $146.27M
Stockholders Equity Q2 2023 · Mar 31, 2022 $175.65M
Stockholders Equity Q2 2023 · Dec 31, 2021 $209.95M
Current Liabilities Q2 2023 · Jun 30, 2023 $57.52M
Current Liabilities Q2 2023 · Dec 31, 2022 $60.57M
Total Liabilities Q2 2023 · Jun 30, 2023 $123.26M
Total Liabilities Q2 2023 · Dec 31, 2022 $120.64M
Current Assets Q2 2023 · Jun 30, 2023 $181.29M
Current Assets Q2 2023 · Dec 31, 2022 $168.15M
Total Assets Q2 2023 · Jun 30, 2023 $232.3M
Total Assets Q2 2023 · Dec 31, 2022 $218.91M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.07
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.18
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.40
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.75
Eps Basic Q2 2023 · Jun 30, 2023 −$0.07
Eps Basic Q2 2023 · Jun 30, 2023 −$0.18
Eps Basic Q2 2023 · Jun 30, 2022 −$0.40
Eps Basic Q2 2023 · Jun 30, 2022 −$0.75
Sga Expense Q2 2023 · Jun 30, 2023 $10.99M
Sga Expense Q2 2023 · Jun 30, 2023 $22.13M
Sga Expense Q2 2023 · Jun 30, 2022 $13.73M
Sga Expense Q2 2023 · Jun 30, 2022 $27.03M
Rd Expense Q2 2023 · Jun 30, 2023 $16.7M
Rd Expense Q2 2023 · Jun 30, 2023 $32.69M
Rd Expense Q2 2023 · Jun 30, 2022 $21.97M
Rd Expense Q2 2023 · Jun 30, 2022 $50.2M
Net Income Q2 2023 · Jun 30, 2023 −$12.31M
Net Income Q2 2023 · Jun 30, 2023 −$29.72M
Net Income Q2 2023 · Mar 31, 2023 −$17.41M
Net Income Q2 2023 · Jun 30, 2022 −$50.92M
Net Income Q2 2023 · Jun 30, 2022 −$95.21M
Net Income Q2 2023 · Mar 31, 2022 −$44.3M
Operating Income Q2 2023 · Jun 30, 2023 −$22.56M
Operating Income Q2 2023 · Jun 30, 2023 −$48.82M
Operating Income Q2 2023 · Jun 30, 2022 −$32.45M
Operating Income Q2 2023 · Jun 30, 2022 −$70.03M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $2.19M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $2.56M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $1.12M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $2.69M
Revenue Q2 2023 · Jun 30, 2023 $7.31M
Revenue Q2 2023 · Jun 30, 2023 $8.55M
Revenue Q2 2023 · Jun 30, 2022 $4.37M
Revenue Q2 2023 · Jun 30, 2022 $9.89M